US Drug Recall Register
Class II · Moderate risk Terminated Initiated Sep 18, 2015 (11 years ago)

Mycamine

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility: Product sterility cannot be guaranteed.

What was recalled

MYCAMINE (micafungin sodium) 150MG, Packaged in 150ML Homepumps, Rx Only. SENTARA HOME HEALTH SENTARA RX, 535 Independence Pkwy ste.300, Chesapeake, VA 23320-5176.

Recalling firm
Sentara Enterprises
Origin
VA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0644-2016

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Micafungin recalls

See all
Class III · Low risk Completed

Micafungin for injection

Reason Cross contamination with other products

Zydus Pharmaceuticals (USA) Inc NDC 16714-301-01 D-0596-2024
Class III · Low risk Completed

Micafungin for injection

Reason Cross contamination with other products

Zydus Pharmaceuticals (USA) Inc NDC 70710-1725-01 D-0595-2024
Class II · Moderate risk Terminated

Micafungin for Injection

Reason Labeling; Incorrect or Missing Package Insert: The package insert provided with the product does not include all required sections approved for this product. This includes aspects of Adverse Reactions, Drug Interactions and Use in Specific Populations.

Xellia Pharmaceuticals USA, LLC NDC 70594-037-01 D-0757-2021
Class II · Moderate risk Terminated

Micafungin for Injection

Reason Labeling; Incorrect or Missing Package Insert: The package insert provided with the product does not include all required sections approved for this product. This includes aspects of Adverse Reactions, Drug Interactions and Use in Specific Populations.

Xellia Pharmaceuticals USA, LLC NDC 70594-036-01 D-0756-2021
Class II · Moderate risk Terminated

Mycamine

Reason Labeling: Label Error on Declared Strength

Astellas Pharma US Inc NDC 0469-3211-10 D-0548-2018